Homepage
Berkeley startup wins government award to develop radiation and lead poisoning treatment
Bakar Labs tenant company HOPO Therapeutics was recently featured in The Los Angeles Times for their technology that can save millions of lives with a single pill. Read post Biocom California Names the Ninth Annual Life Science Catalyst Award Winners
Sophia Lugo, CEO and co-founder of Bakar Labs tenant company Radar Therapeutics, has been selected as one of the recipients of the award. The Catalyst Award recognizes 10 life science trailblazers under the age of 40 across California. Read post
HOPO Therapeutics wins up to $226M BARDA contract for heavy metal poisoning research
Endpoints News covered HOPO Therapeutics’ recent accomplishment of securing a $226 million contract with BARDA. Read post HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity
The funds will be used to advance development of the drug candidate HOPO-101 through registrational studies as a medical countermeasure against radiological threats, including planned submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). The initial award of approximately $9.4 million will fund toxicology and pharmacology studies, manufacturing activities, and nonclinical research in other types of heavy metal poisoning, with approximately $216 million in additional funding available for later-stage development upon agreement between BARDA and HOPO. Read post
Tenant Spotlight on Aikium: A Trillion Shots at Targeting Tangled Proteins
Aikium has essentially invented a new protein family. Called “SeqR” proteins, they are sequence specific binders that can be applied to different therapeutic needs such as cancer, neuro-inflammation, and some autoimmune disorders. Aikium is going after chemokine receptors, a subset of G-protein coupled receptors, a large class of molecules that have long proven difficult to target. By virtue of being on immune cells, they are front and center in cancer and immune-mediated diseases. Read post
Bakar Labs Named a Finalist for 2024 Pantheon Awards
We’re excited to announce that California Life Sciences has selected us as a finalist for the 2024 Pantheon Awards! Want to support our mission? Vote for Bakar Labs in the academic/non-profit category (the deadline is October 15). Read post
NIH Awards ResVita Bio a $2M Phase II SBIR Grant for Continuous Protein Therapy for Netherton Syndrome
ResVita Bio is pioneering continuous protein therapy, delivered through a genetically engineered probiotic platform that temporarily colonizes the skin and continuously releases therapeutic proteins, such as LEKTI, to inhibit protease activity. This continuous delivery method ensures high levels of the therapeutic agent at the site of damage, restoring the integrity of the skin barrier. This represents a significant shift from traditional therapies, which may not provide sustained treatment at the site of the disease. Read postOur affiliates
Ready to run?
Startups need to focus on making milestones, not managing equipment.
Bakar Labs maintains tissue culture facilities, a freezer farm, fume hoods, basic benchtop equipment and plenty of analytical instruments. Optional lab support services can also make for quick starts that help get results fast.
At UC Berkeley
Bakar Labs is just steps from UC Berkeley’s world-renowned faculty and more than 40,000 students who train in top programs including science, engineering, law and business. Dotting the campus is a network of core facilities that feature a wide range of advanced equipment and services for use by startups. Recruiting student talent and scientific co-founders couldn’t be easier.
Today’s best startups blaze a trail all their own, but they don’t do it alone.
They build their support network to help them navigate the multiple challenges they face. At Bakar Labs, tenants join a community of as many as 50 like-minded teams willing to share the scientific and business insights that help them advance. The incubator spans more than 40,000 square feet of lab and office spaces within the fully renovated Woo Hon Fai Hall, the iconic former home of the Berkeley Art Museum. With so much going on, investors, industry partners and new talent are already taking notice.
Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.
